Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wildemann

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System GliomaFlorian Iser, Felix Hinz, Dirk C Hoffmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 7, 2020
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosisSargis Abrahamyan, Bettina Eberspächer, Muna-Miriam Hoshi, et al.
Journal of Neurology|October 13, 2016
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndromeAndré M Huss, Steffen Halbgebauer, Patrick Öckl, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Annals of Neurology|December 30, 2021
Subcortical Volumes as Early Predictors of Fatigue in Multiple SclerosisVinzenz Fleischer, Dumitru Ciolac, Gabriel Gonzalez-Escamilla, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System GliomaFlorian Iser, Felix Hinz, Dirk C Hoffmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 7, 2020
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosisSargis Abrahamyan, Bettina Eberspächer, Muna-Miriam Hoshi, et al.
Journal of Neurology|October 13, 2016
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndromeAndré M Huss, Steffen Halbgebauer, Patrick Öckl, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
Journal of Neuroinflammation|October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeSven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Annals of Neurology|December 30, 2021
Subcortical Volumes as Early Predictors of Fatigue in Multiple SclerosisVinzenz Fleischer, Dumitru Ciolac, Gabriel Gonzalez-Escamilla, et al.
Pageof 21